Get started
Author

Samantha Westelman

PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression
2024 · Christin Schmidt, Sarah Cohen, et al. · Scientific Reports · 14
PDF
Human stem cell models for group 3 medulloblastoma uncover JARID1B as a regulator of the chromatin landscape
2025 · Zulekha A. Qadeer, Elise Hou, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Epco-47. Dissecting Myc-driven Epigenetic Mechanisms That Promote Group 3 Medulloblastoma Utilizing Humanized Ipsc Models
2025 · Zulekha Qadeer, Elise Hou, et al. · Neuro-Oncology
PDF
MDB-29. Humanized iPSC models for group 3 medulloblastoma reveal key context-specific functions for MYC in remodeling the chromatin landscape.
2025 · Zulekha Qadeer, Dara Siegel, et al. · Neuro-Oncology Pediatrics
Mdb-08. Myc and Tgfβ Promote Group 3 Medulloblastoma Tumor Resistance Through Deregulation of Polycomb Targets
2024 · Zulekha A Qadeer, Samantha Westelman, et al. · Neuro-Oncology
PDF
Mdb-32. Prdm6 Promotes Medulloblastoma Formation in Neuroepithelial Stem Cells and Is a Chromatin Repressor by Binding to Histone H3 Lysine 27 Trimethylation Marks
2024 · Christin Schmidt, Sarah Cohen, et al. · Neuro-Oncology
Mdb-09. Impact of Prdm6 on Chromatin Accessibility, Gene Expression, and Medulloblastoma Formation
2023 · Christin Schmidt, Sarah Husain, et al. · Neuro-Oncology
PDF
Mdb-07. Myc and Tgfβ Promote Group 3 Medulloblastoma Tumor Resistance Through Deregulation of Kdm2b Targets
2023 · Zulekha Qadeer, Samantha Westelman, et al. · Neuro-Oncology
PDF
Dddr-33. Targeting Tgfβ Pathway Dependencies in Group 3 Medulloblastoma
2022 · Zulekha Qadeer, Samantha Westelman, et al. · Neuro-Oncology
PDF
Modl-32. Impact of Prdm6 on Chromatin Accessibility, Gene Expression, and Medulloblastoma Formation
2022 · Christin Schmidt, Sarah Husain, et al. · Neuro-Oncology
PDF
Works count: 10
Citation count: 14
H-index: 1
I10-index: 1
Year
Topic
Type